Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Adductor Canal Catheters for Post-TKA Pain
NCT05053087Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2022
- Primary completion
- Feb 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Mayo Clinic. Started Apr 2022; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05053087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05053087.